Navigation Links
Inverness Medical Innovations Announces Second Quarter 2008 Results
Date:7/29/2008

available to common stockholders

of $30.4 million. Potential dilutive shares consisting of 6,008,000 common

stock equivalent shares from the potential conversion of Series B

convertible preferred stock for the three months ended June 30, 2008 were

not used in the calculation of diluted net income per common share, on an

adjusted cash basis, because inclusion thereof would be antidilutive.

(k) Included in the weighted average diluted common shares for the

calculation of net income per common share for the three months ended June

30, 2007, on an adjusted cash basis, are dilutive shares consisting of

1,841,000 common stock equivalent shares from the potential exercise of

stock options and warrants. Potential dilutive shares consisting of

1,513,000 common stock equivalent shares from the potential conversion of

convertible debt securities for the three months ended June 30, 2007 were

not used in the calculation of diluted net income per common share, on an

adjusted cash basis, because inclusion thereof would be antidilutive.

Inverness Medical Innovations, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and

Reconciliation to Non-GAAP Adjusted Cash Basis Amounts

(in $000s, except per share amounts)

Six Months Ended June 30, 2008

Non-GAAP

Adjusted

Non-GAAP Cash

GAAP Adjustments Basis (a)

Net revenue $773,360 $- $773,360

Cost of revenue 386,868 (40,839)(b)(c)(d)(e) 346,029

Gross profit 386,492 40,839
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
2. Inverness - Chemogen Establish Exclusive License for TB Antibodies
3. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
4. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
7. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015  Peter Walter wurde als Gewinner ... seine bahnbrechende Arbeit ausgewählt, die sich damit ... sowie für die Entschlüsselung der Komponenten eines ... nutzen, der mit der Ansammlung von deformierten ... Biochemie an der University of California, San ...
(Date:3/27/2015)... 2015 Working in collaboration with the ... London , Richmond Pharmacology is the first centre ... study for an investigational RNAi therapeutic being developed for the ... nerves and heart. Read press release ... Based at St Georges University of London ...
(Date:3/26/2015)... WARREN, N.J., March 26, 2015  Roka Bioscience, ... company focused on providing advanced testing solutions for ... financial results for the three months and full ... Quarter 2014 Financial Results:Revenue for the quarter ended ... $689,000 for the fourth quarter of 2013 and ...
(Date:3/26/2015)... March 26, 2015  BioNano Genomics, Inc., the leader ... Salyer as chief commercial officer. Salyer has more ... sales teams in life sciences. At BioNano, Salyer will ... a genome-mapping platform to assemble a comprehensive view of ... To date, 32 institutions located in the ...
Breaking Biology Technology:Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3
... , FREISING-WEIHENSTEPHAN, Germany, September 15 ... a collaboration agreement with,Allergan, Inc. (NYSE: AGN ... in drug delivery and ophthalmic drug,development with a goal ... , Under the terms of ...
... ... use an electric breast pump in public with her new patented device that allows a ... changer for breastfeeding mothers in the workplace, as anchorwoman attests, "It works!" , ... Sacramento, CA (PRWEB) September 15, 2009 -- ...
... , , BALTIMORE, Sept. 14 ... engaged in the development of advanced preclinical platforms and tumor specific ... financial results for the first quarter ended July 31, 2009. Full ... Form 10-Q at www.championsbiotechnology.com . , , ...
Cached Biology Technology:Pieris AG Enters into Anticalin Collaboration With Allergan, Inc. 2ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System 2ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System 3ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System 4Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results 5
(Date:3/23/2015)... --NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet, ... March 30 th . The new ... York markets. Gino Pereira ... new ad campaign following the recent initial shipment of Wocket ...
(Date:3/20/2015)... Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the addition ... report to their offering. This report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:3/20/2015)... Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced the addition ... report to their offering. This report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... Prevention and Treatment of Cardiovascular Disease , ... the occasion, the Journal of the American Dietetic ... factors for treating and preventing cardiovascular disease. The ... and other articles provide scientific rationale for food ...
... worlds poorest regions could face severe crop losses in the ... new study by researchers at Stanford Universitys Program on Food ... published in the Feb. 1 issue of the journal Science. ... on agriculture for their livelihoods, said lead author David Lobell, ...
... blood vessels is by creating too much competition for an ... That amino acid, L-arginine, is broken down by the enzyme ... from the proteins we eat. Diabetics have a lot of ... says Dr. Maritza Romero, postdoctoral fellow at the Medical College ...
Cached Biology News:Highlights from the February 2008 Journal of the American Dietetic Association 2Highlights from the February 2008 Journal of the American Dietetic Association 3Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 2Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 3Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 4Diabetes makes it hard for blood vessels to relax 2
... Monoclonal Antibody, Unconjugated Applications: ... ICC: Use at an assay dependent dilution. WB: ... ug/ml, this concentration is determined using a whole ... kDa. Not tested in other applications. Optimal ...
Monoclonal Anti-Gα o purified immunoglobulin buffered aqueous solution Solution in phosphate buffered saline pH 7.4, containing 0.08% sodium azide. partially purified bovine brain Gα O ...
SHP-2 Antibody...
Anti human PPAR gamma2 mouse monoclonal antibody...
Biology Products: